Hidden costs associated with venous thromboembolism: impact of lost productivity on employers and employees.
| Autor: | Page RL 2nd; From the Department of Clinical Pharmacy (Drs Page, Ghushchyan, and Nair), Skaggs School of Pharmacy and Pharmaceutical Sciences; Department of Physical Medicine (Dr Page), School of Medicine, University of Colorado, Aurora; College of Business and Economics (Dr Ghushchyan), American University of Armenia, Yerevan; Integrated Benefits Institute (Dr Gifford), San Francisco, Calif; Peakstat Statistical Services (Mr Read), Evergreen, Colo; and Janssen Scientific Affairs (Dr Raut, Mr Bookhart, and Dr Naim), LLC, Raritan, NJ., Ghushchyan V, Gifford B, Read RA, Raut M, Bookhart BK, Naim AB, Damaraju CV, Nair KV |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of occupational and environmental medicine [J Occup Environ Med] 2014 Sep; Vol. 56 (9), pp. 979-85. |
| DOI: | 10.1097/JOM.0000000000000208 |
| Abstrakt: | Objective: To determine productivity loss and indirect costs with deep vein thrombosis (DVT) and pulmonary embolism (PE). Methods: Medical and pharmacy claims with short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 were analyzed from the Integrated Benefits Institute's Health and Productivity Benchmarking (IBI-HPB) database (STD and LTD claims) and IMS LifeLink™ data (medical and pharmacy claims), which were indirectly linked using a weighting approach matching from IBI-HPB patients' demographic distribution. Results: A total of 5442 DVT and 6199 PE claims were identified. Employees with DVT lost 57 STD and 440 LTD days per disability incident. The average per claim productivity loss from STD and LTD was $7414 and $58181, respectively. Employees with PE lost 56 STD and 364 LTD days per disability incident. The average per claim productivity loss from STD and LTD was $7605 and $48,751, respectively. Conclusions: Deep vein thrombosis and PE impose substantial economic burdens. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|